Product image of Memantina Camriz (Memantine Hydrochloride) supplied by GNH India

Memantina Camriz

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantina Camriz (Memantine Hydrochloride)

Memantine Hydrochloride, the active ingredient in Memantina Camriz, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adults.

GNH India supplies Memantina Camriz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantina Camriz is a NMDA receptor antagonist indicated for the treatment of Alzheimer’s disease and related symptoms.

  • Alzheimer's disease (moderate to severe): improves cognition, memory and daily functioning.
  • Alzheimer's disease (mild to moderate): may provide modest cognitive benefit and delay functional decline.
  • Behavioral symptoms in Alzheimer’s disease: can reduce agitation and aggression in some patients.

How It Works

  • Memantine Hydrochloride acts as a non‑competitive antagonist at the NMDA (N‑methyl‑D‑aspartate) receptor. By binding to the receptor-associated ion channel, it reduces excessive calcium influx caused by glutamate over‑activation, thereby decreasing excitotoxic neuronal injury and helping to preserve synaptic function in the brain.

Side Effects

Memantina Camriz may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects

  • Dizziness: transient light‑headedness, especially on standing.
  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Fatigue: feeling of tiredness or lack of energy.
  • Nausea: occasional upset stomach.
  • Confusion: temporary disorientation.

Serious or Rare Side Effects

  • Seizures: rare occurrence of convulsive episodes.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Hallucinations: visual or auditory disturbances.
  • Hypertension: unexpected rise in blood pressure.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Liver enzyme elevation: abnormal liver function tests.

Precautions & Warnings

Before initiating therapy with Memantina Camriz, consider the following safety measures.

  • Renal impairment: adjust dose or monitor renal function.
  • Hepatic disease: use with caution and monitor liver enzymes.
  • Concomitant CNS depressants: assess for additive sedation.
  • History of seizures: evaluate risk versus benefit.
  • Pregnancy and breastfeeding: avoid unless clearly needed.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Avoid Interactions

Memantina Camriz can interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Amantadine: may increase risk of neurotoxicity.
  • NMDA agonists: antagonistic effect may reduce therapeutic benefit.
  • Strong CYP3A4 inducers: may lower memantine plasma levels.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may worsen cognitive side effects.
  • CNS depressants (e.g., benzodiazepines): monitor for enhanced sedation.
  • Diuretics: watch for electrolyte disturbances.
  • Antihypertensives: possible additive blood pressure effects.

Frequently Asked Questions

Memantina Camriz contains memantine hydrochloride, which is prescribed to treat moderate to severe Alzheimer’s disease. It helps improve cognition, memory, and daily functioning by protecting neurons from excitotoxic damage caused by excessive glutamate activity.

Memantine acts as a non‑competitive antagonist at NMDA receptors. By blocking the receptor‑associated ion channel, it reduces calcium influx that results from glutamate over‑stimulation, thereby limiting neuronal injury and supporting synaptic health in patients with Alzheimer’s disease.

The specific dose of Memantina Camriz is determined by the prescribing clinician based on the patient’s condition, renal function, and treatment response. Healthcare professionals adjust the regimen to achieve optimal therapeutic effect while minimizing adverse reactions.

Safety data for memantine in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both improve cognition, memantine is typically used for moderate to severe disease and may be combined with an inhibitor for additive benefit, whereas inhibitors are often first‑line for mild disease.

Memantina Camriz should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains sealed until use.

The medication is taken orally, usually once daily, with or without food. Patients should follow the prescribing clinician’s instructions regarding timing and whether the tablet should be swallowed whole or divided, if permitted.

Serious adverse events, though uncommon, include seizures, severe allergic reactions, hallucinations, and significant hypertension. Patients should seek immediate medical attention if they experience any of these symptoms while on therapy.

Memantina Camriz is contraindicated in patients with known hypersensitivity to memantine or any excipients in the formulation. Caution is also advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, unless a clinician determines the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT